A Generalizable, Data-Driven Approach to Predict Daily Risk of Clostridium difficile Infection at Two Large Academic Health Centers

OBJECTIVE An estimated 293,300 healthcare-associated cases of Clostridium difficile infection (CDI) occur annually in the United States. To date, research has focused on developing risk prediction models for CDI that work well across institutions. However, this one-size-fits-all approach ignores important hospital-specific factors. We focus on a generalizable method for building facility-specific models. We demonstrate the applicability of the approach using electronic health records (EHR) from the University of Michigan Hospitals (UM) and the Massachusetts General Hospital (MGH). METHODS We utilized EHR data from 191,014 adult admissions to UM and 65,718 adult admissions to MGH. We extracted patient demographics, admission details, patient history, and daily hospitalization details, resulting in 4,836 features from patients at UM and 1,837 from patients at MGH. We used L2 regularized logistic regression to learn the models, and we measured the discriminative performance of the models on held-out data from each hospital. RESULTS Using the UM and MGH test data, the models achieved area under the receiver operating characteristic curve (AUROC) values of 0.82 (95% confidence interval [CI], 0.80–0.84) and 0.75 ( 95% CI, 0.73–0.78), respectively. Some predictive factors were shared between the 2 models, but many of the top predictive factors differed between facilities. CONCLUSION A data-driven approach to building models for estimating daily patient risk for CDI was used to build institution-specific models at 2 large hospitals with different patient populations and EHR systems. In contrast to traditional approaches that focus on developing models that apply across hospitals, our generalizable approach yields risk-stratification models tailored to an institution. These hospital-specific models allow for earlier and more accurate identification of high-risk patients and better targeting of infection prevention strategies. Infect Control Hosp Epidemiol 2018;39:425–433

[1]  Siddharth Singh,et al.  Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis , 2017, JAMA internal medicine.

[2]  M. Olsen,et al.  Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. , 2007, Archives of internal medicine.

[3]  T. McGinn,et al.  Developing a Clinical Prediction Rule for First Hospital-Onset Clostridium difficile Infections: A Retrospective Observational Study , 2016, Infection Control & Hospital Epidemiology.

[4]  C. Eckert,et al.  Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management? , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  G. Ginsberg,et al.  Implementation of a systematic culturing program to monitor the efficacy of endoscope reprocessing: outcomes and costs. , 2016, Gastrointestinal endoscopy.

[6]  Helen Burstin,et al.  Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.

[7]  K. Garey,et al.  A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection , 2015, PloS one.

[8]  Jenna Wiens,et al.  Patient Risk Stratification with Time-Varying Parameters: A Multitask Learning Approach , 2016, J. Mach. Learn. Res..

[9]  V. Young,et al.  Probiotics for prevention of Clostridium difficile infection , 2018, Current opinion in gastroenterology.

[10]  S. Trottier,et al.  Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study. , 2016, JAMA internal medicine.

[11]  S. Chandra,et al.  Validation of a Clinical Prediction Scale for Hospital-onset Clostridium difficile Infection , 2013, Journal of clinical gastroenterology.

[12]  Jenna Wiens,et al.  A study in transfer learning: leveraging data from multiple hospitals to enhance hospital-specific predictions , 2014, J. Am. Medical Informatics Assoc..

[13]  D. Anderson,et al.  Decontamination of Targeted Pathogens from Patient Rooms Using an Automated Ultraviolet-C-Emitting Device , 2013, Infection Control & Hospital Epidemiology.

[14]  T. Horan,et al.  Recommendations for Surveillance of Clostridium difficile–Associated Disease , 2007, Infection Control & Hospital Epidemiology.

[15]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[16]  Daniel Hind,et al.  Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme , 2017, BMJ Open.

[17]  Ella S. Franklin,et al.  Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile , 2014, Open forum infectious diseases.

[18]  D. Yokoe,et al.  Clinical Risk Factors for Severe Clostridium difficile–associated Disease , 2009, Emerging infectious diseases.

[19]  D. Pegues,et al.  Cleaning Hospital Room Surfaces to Prevent Health Care-Associated Infections: A Technical Brief. , 2015, Annals of internal medicine.

[20]  Linnea A. Polgreen,et al.  Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI. , 2016, American journal of infection control.

[21]  Kimberly A. Reske,et al.  Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study , 2014, BMC Infectious Diseases.

[22]  M. Falagas,et al.  Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. , 2016, International journal of antimicrobial agents.

[23]  Lisa G Winston,et al.  Burden of Clostridium difficile Infection in the United States , 2015 .

[24]  Heidi Whalen,et al.  The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies , 2017, Antimicrobial Agents and Chemotherapy.

[25]  Subhashini Venugopalan,et al.  Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.

[26]  C. Donskey,et al.  Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update , 2014, Infection Control & Hospital Epidemiology.

[27]  G. DiDiodato,et al.  Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study , 2016, PloS one.

[28]  A. Akram,et al.  Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia. , 2016, The Journal of infection.

[29]  F. Manian,et al.  Implementation of hospital-wide enhanced terminal cleaning of targeted patient rooms and its impact on endemic Clostridium difficile infection rates. , 2013, American journal of infection control.

[30]  A. Evans,et al.  Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis. , 2017, Gastroenterology.

[31]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.